The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

The CDDF Community



Join the CDDF community: working together to find ways to accelerate oncology drug development and deliver optimal treatment to cancer patients


The CDDF has developed a community of stakeholders who support the shared mission to facilitate debate and progress in the field of oncology drug development. Non-commercial organisations (academia, NGOs and associations), healthcare companiesregulatory agencies and patient groups involved in cancer research can become part of the collaborative CDDF network. The CDDF believes that collaboration plays a crucial role in overcoming challenges in the development of cancer drugs. By establishing the multi-stakeholder network and working together constructively, we can achieve our goal to increase efficiency in cancer drug development and accelerate the delivery of effective oncology treatment to patients.

We thank CDDF members and collaborators for their ongoing support.


The CDDF collaborates with representatives from regulatory authorities to access their viewpoint on oncology drug development.


CDDF industry members provide the perspective of healthcare companies on challenges to be addressed in cancer drug development.


The CDDF collaborates closely with the following organisations whose missions are in alignment with the CDDF’s.


The CDDF works closely with patient advocacy groups to incorporate patient perspectives into discussions.

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70